Food allergy, intolerance, and sensitivity generally differ based on whether or not IgE, a protein the body can make against ...

Omalizumab superior to oral immunotherapy for multifood allergy, and most patients consume allergy-triggering foods after gaining tolerance.

Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV Technologies increased from 12 months through 60 months, according to an abstract ...

SAN DIEGO -- A research tool more often used in dermatology that monitors water loss from skin may help allergists stop an ...

Early dietary diversity in infants may reduce the risk of food allergies by promoting immune tolerance and gut microbiome ...

Omalizumab treats multi-food allergy better than oral immunotherapy: Study: Bethesda, Maryland Wednesday, March 5, 2025, 11:00 Hrs [IST] A clinical trial has found that the medica ...

Misdiagnosed Chronic Diseases can lead to long-Term Harm to Physical and Mental Health, Study revealsA ‘chasm of misunderstanding and miscommunication’ ...

Biologic treatment for atopic dermatitis appeared to improve growth trajectories for younger children, a trial analysis ...

Omalizumab (Xolair) injections outperformed oral immunotherapy (OIT) in increasing tolerance among children with multi-food ...

Edamame is a healthy source of protein and fiber. It’s mostly imported from Asia, but harvests in the United States are ...

The study suggests that omalizumab could become a safer, more effective alternative to OIT for people with highly sensitive ...

Millions of people in the U.S. each year deal with symptoms of seasonal allergies caused by distinct types of pollen.